EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitVergleichsstudie

Efficacy of ketamine versus esketamine in the treatment of perioperative depression: A review

Wen Wen, Zhao Wenjing, Xing Xia, Xiangjun Duan, Liang Zhang, Lin Duomao, Qi Zeyou, Sheng Wang, Mingxin Gao, Changcheng Liu, Haiyang Li, Jun Ma

Pharmacology Biochemistry and Behavior · 2024

DOI: 10.1016/j.pbb.2024.173773 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmacology Biochemistry and Behavior, 2024. Verfasst von Wen Wen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Anzhen Hospital, Capital Medical University. Hauptthemen laut MEDLINE: Ketamine, Antidepressive Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 143 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Depression is a significant factor contributing to postoperative occurrences, and patients diagnosed with depression have a higher risk for postoperative complications. Studies on cardiovascular surgery extensively addresses this concern. Several studies report that people who undergo coronary artery bypass graft surgery have a 20% chance of developing postoperative depression. A retrospective analysis of medical records spanning 21 years, involving 817 patients, revealed that approximately 40% of individuals undergoing coronary artery bypass grafting (CABG) were at risk of perioperative depression. Patients endure prolonged suffering from illness because each attempt with standard antidepressants requires several weeks to be effective. In addition, multi-drug combination adjuvants or combination medication therapy may alleviate symptoms for some individuals, but they also increase the risk of side effects. Conventional antidepressants primarily modulate the monoamine system, whereas different therapies target the serotonin, norepinephrine, and dopamine systems. Esketamine is a fast-acting antidepressant with high efficacy. Esketamine is the S-enantiomer of ketamine, a derivative of phencyclidine developed in 1956. Esketamine exerts its effect by targeting the glutaminergic system the glutaminergic system. In this paper, we discuss the current depression treatment strategies with a focus on the pharmacology and mechanism of action of esketamine. In addition, studies reporting use of esketamine to treat perioperative depressive symptoms are reviwed, and the potential future applications of the drug are presented.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KetamineAntidepressive AgentsHumansDepressionPostoperative ComplicationsAnimalsPerioperative PeriodTreatment Outcome

Stichwörter der Autor:innen

AnesthesiologyCardiac surgeryDepressionEsketamineKetamine

Substanzen

KetamineEsketamineAntidepressive Agents

Autor:innen und Institutionen

  • Beijing Anzhen Hospital, Capital Medical University.
  • Beijing Anzhen Hospital, Capital Medical University. Electronic address: ocean0203@163.com.
  • Beijing Anzhen Hospital, Capital Medical University. Electronic address: 18710168703@163.com.

Zitieren

APA

Wen, W., Wenjing, Z., Xia, X., Duan, X., Zhang, L., Duomao, L., Zeyou, Q., Wang, S., Gao, M., Liu, C., Li, H., & Ma, J. (2024). Efficacy of ketamine versus esketamine in the treatment of perioperative depression: A review. Pharmacology Biochemistry and Behavior. https://doi.org/10.1016/j.pbb.2024.173773

Vancouver

Wen W, Wenjing Z, Xia X, Duan X, Zhang L, Duomao L, et al. Efficacy of ketamine versus esketamine in the treatment of perioperative depression: A review. Pharmacology Biochemistry and Behavior. 2024. doi:10.1016/j.pbb.2024.173773

BibTeX
@article{Wen2024,
  author = {Wen, Wen and Wenjing, Zhao and Xia, Xing and Duan, Xiangjun and Zhang, Liang and Duomao, Lin and Zeyou, Qi and Wang, Sheng and Gao, Mingxin and Liu, Changcheng and Li, Haiyang and Ma, Jun},
  title = {Efficacy of ketamine versus esketamine in the treatment of perioperative depression: A review},
  journal = {Pharmacology Biochemistry and Behavior},
  year = {2024},
  doi = {10.1016/j.pbb.2024.173773}
}
Kostenlos starten →